Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedFooter now displays the revised site version 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This marks a minor update to the page template.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now displays a newer software/site revision identifier (“Revision: v3.5.3”) rather than the previous one (“Revision: v3.5.2”). This reflects a version update of the ClinicalTrials.gov page tooling rather than any change to the underlying study information.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded the hepatocellular carcinoma term and a Genetic and Rare Diseases Information Center resource; updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices about government funding and NIH Clinical Center operating status. These are administrative updates that do not modify the study details.SummaryDifference0.4%

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.